Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 1
2014 2
2016 3
2017 2
2018 2
2019 1
2020 3
2021 3
2022 5
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia.
Jetani H, Navarro-Bailón A, Maucher M, Frenz S, Verbruggen C, Yeguas A, Vidriales MB, González M, Rial Saborido J, Kraus S, Mestermann K, Thomas S, Bonig H, Luu M, Monjezi R, Mougiakakos D, Sauer M, Einsele H, Hudecek M. Jetani H, et al. Blood. 2021 Nov 11;138(19):1830-1842. doi: 10.1182/blood.2020009192. Blood. 2021. PMID: 34289026 Free PMC article.
Automated, scaled, transposon-based production of CAR T cells.
Lock D, Monjezi R, Brandes C, Bates S, Lennartz S, Teppert K, Gehrke L, Karasakalidou-Seidt R, Lukic T, Schmeer M, Schleef M, Werchau N, Eyrich M, Assenmacher M, Kaiser A, Prommersberger S, Schaser T, Hudecek M. Lock D, et al. J Immunother Cancer. 2022 Sep;10(9):e005189. doi: 10.1136/jitc-2022-005189. J Immunother Cancer. 2022. PMID: 36096530 Free PMC article.
Pairing of single-cell RNA analysis and T cell antigen receptor profiling indicates breakdown of T cell tolerance checkpoints in atherosclerosis.
Wang Z, Zhang X, Lu S, Zhang C, Ma Z, Su R, Li Y, Sun T, Li Y, Hong M, Deng X, Monjezi MR, Hristov M, Steffens S, Santovito D, Dornmair K, Ley K, Weber C, Mohanta SK, Habenicht AJR, Yin C. Wang Z, et al. Nat Cardiovasc Res. 2023 Mar;2(3):290-306. doi: 10.1038/s44161-023-00218-w. Epub 2023 Feb 23. Nat Cardiovasc Res. 2023. PMID: 37621765 Free PMC article.
The Association Between Hepatitis B Virus Mutations and the Risk of Liver Disease and Hepatocellular Carcinoma.
Akrami H, Monjezi MR, Ilbeigi S, Amiri F, Fattahi MR. Akrami H, et al. Curr Mol Med. 2022;22(6):514-523. doi: 10.2174/1566524021666210816094412. Curr Mol Med. 2022. PMID: 34397330 Review.
This review article mainly focuses on the HBV mutations which correlated to occult HBV infection, immune escape, vaccine failure and eventually liver cirrhosis and HCC. The current study indicated that preS/S region mutations are related to vaccine failure, immune escape, …
This review article mainly focuses on the HBV mutations which correlated to occult HBV infection, immune escape, vaccine failure and eventua …
Effects of exosomes of mesenchymal stem cells on cholesterol-induced hepatic fibrogenesis.
Rashidi M, Matour E, Monjezi S, Asadi Zadeh S, Shakerian E, Sabahy S, Afarin R. Rashidi M, et al. Iran J Basic Med Sci. 2023;26(6):695-700. doi: 10.22038/IJBMS.2023.68858.15003. Iran J Basic Med Sci. 2023. PMID: 37275763 Free PMC article.
In this study, we investigated the ability of exosomes of WJ-MSCs as a new remedy to reduce cholesterol-induced liver fibrosis in the LX2 cell line. MATERIALS AND METHODS: MSCs were isolated from Wharton's jelly of the umbilical cord and the exosomes were extracted. ...CON …
In this study, we investigated the ability of exosomes of WJ-MSCs as a new remedy to reduce cholesterol-induced liver fibrosis in the LX2 ce …
25 results